Log in

canadian entrepreneurs

in life science

Become a CELS Member Today!

Most CELS events including VR Webinars include a coupon code for free individual and Start-Up (Bundled Individual) memberships, that can be used here. Join CELS now to start exploring your instant Life Science network!

IP and Startup Valuations in Times of Crisis

  • June 19, 2020
  • 11:00 AM - 12:00 PM
  • Webinar


  • Public Access Webinar for the Global Life Sciences Community

Registration is closed

Intellectual property (IP) is the most valuable asset for Life Sciences and Medical Device companies, particularly in the early, pre-revenue stage. The recent COVID-19 pandemic has created a new reality for IP and technology licensing, which could have a profound impact on valuations and licensing opportunities. Efrat Kasznik, a valuation expert and Stanford lecturer, will share her insights from valuing IP and startups in the Biotech, Pharma and Medical Device sectors, serving clients including: Covidien, Abbott Labs and Omron.

Key Takeaways:

  • Trends in early stage life-sciences company valuations and exits.
  • The correlation between life-science company valuations and their intellectual property (IP) position.
  • Recent IP developments related to COVID-19 and their impact on valuation.
  • Maximizing value in the post-COVID-19 life-sciences market.


Date: Friday, June 19, 2020

Time: 11:00 am - 12:00 pm PDT (Pacific Time)

Join Info: Dial-in & Web Access Information Provided with Registration Confirmation Email


Efrat Kasznik

President of Foresight Valuation Group, LLC


Efrat Kasznik is President of Foresight Valuation Group and a Lecturer at the Stanford Graduate School of Business. Efrat is a Silicon-Valley based valuation and intellectual property expert with two decades of consulting experience, focusing on assisting IP holders across industries with the valuation and monetization of their innovation. She helps clients, ranging in size from Fortune 100 companies to start-ups, with IP and business valuations in support of licensing deals, IP and technology acquisitions, M&A transactions, financial reporting, strategic planning, and fundraising. She frequently serves as a testifying expert in legal disputes involving IP and startup valuations and damages. Efrat currently serves as Chair of the High-Tech Sector – Licensing Executives Society (LES) and has been recognized as a top IP strategist on the IAM 300 list every year since 2013.


© 2022 Canadian Entrepreneurs in Life Science. All Rights Reserved.